Details
Stereochemistry | ACHIRAL |
Molecular Formula | C30H37N3O7S |
Molecular Weight | 583.696 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(NS(C)(=O)=O)C=C(C=C1NC(=O)C(=O)C2=C3C=CC=CC3=C(OCCN4CCOCC4)C=C2)C(C)(C)C
InChI
InChIKey=UUROSJLZNDSXRF-UHFFFAOYSA-N
InChI=1S/C30H37N3O7S/c1-30(2,3)20-18-24(28(38-4)25(19-20)32-41(5,36)37)31-29(35)27(34)23-10-11-26(22-9-7-6-8-21(22)23)40-17-14-33-12-15-39-16-13-33/h6-11,18-19,32H,12-17H2,1-5H3,(H,31,35)
Molecular Formula | C30H37N3O7S |
Molecular Weight | 583.696 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor. | 2009 Dec |
|
Targeting HCV entry for development of therapeutics. | 2010 Aug |
|
Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors. | 2011 Jan |
|
Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antivirals. | 2012 Feb 15 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24041792
150 mg/day by mouth for 3, 14, or 28 days.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 03:22:54 GMT 2023
by
admin
on
Sat Dec 16 03:22:54 GMT 2023
|
Record UNII |
RDD1D7O9YX
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
848144-15-0
Created by
admin on Sat Dec 16 03:22:54 GMT 2023 , Edited by admin on Sat Dec 16 03:22:54 GMT 2023
|
PRIMARY | |||
|
11786594
Created by
admin on Sat Dec 16 03:22:54 GMT 2023 , Edited by admin on Sat Dec 16 03:22:54 GMT 2023
|
PRIMARY | |||
|
RDD1D7O9YX
Created by
admin on Sat Dec 16 03:22:54 GMT 2023 , Edited by admin on Sat Dec 16 03:22:54 GMT 2023
|
PRIMARY | |||
|
DTXSID00233876
Created by
admin on Sat Dec 16 03:22:54 GMT 2023 , Edited by admin on Sat Dec 16 03:22:54 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|